Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial ...
Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.